Publications

5891 Results

Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy [PMID17389240; PMC2118551]

Authors
R Spisek;A Kukreja;LC Chen;P Matthews;A Mazumder;D Vesole;S Jagannath;HA Zebroski;AJG Simpson;G Ritter;B Durie;J Crowley;JD Shaughnessy Jr;MJ Scanlan;AO Gure;B Barlogie;MV Dhodapkar
Journal / Conference
Journal of Experimental Medicine 204(4):831-840
Year
2007
Research Committee(s)
Myeloma
Study Number(s)
S0120

Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival [PMID17299095; PMC1885523]

Authors
A Wiestner;M Tehrani;M Chiorazzi;G Wright;F Gibellini;K Nakayama;H Liu;A Rosenwald;HK Muller-Hermelink;G Ott;WC Chan;TC Greiner;DD Weisenburger;J Vose;JO Armitage;RD Gascoyne;JM Connors;E Campo;E Montserrat;F Bosch;EB Smeland;S Kvaloy;H Holte;J Delabie;RI Fisher;TM Grogan;TP Miller;WH Wilson;EJ Jaffe;LM Staudt
Journal / Conference
Blood 109(11):4599-4606
Year
2007
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

Revised response criteria for malignant lymphoma

Authors
BD Cheson;B Pfistner;ME Juweid;RD Gascoyne;L Specht;SJ Horning;B Coiffier;RI Fisher;A Hagenbeck;E Zucca;ST Rosen;S Stroobants;TA Lister;RT Hoppe;M Dreyling;K Tobinai;JM Vose;JM Connors;M Federico;V Diehl
Journal / Conference
Journal of Clinical Oncology 25(5):579-586
Year
2007
Research Committee(s)
Lymphoma
PMID
PMID17242396

A multi center trial of hyperCVAD+rituxan in patients with newly diagnosed mantle cell lymphoma

Authors
EM Epner;J Unger;T Miller;L Rimsza;C Spier;M LeBlanc;R Fisher
Journal / Conference
Blood 110(11):#387
Year
2007
Research Committee(s)
Lymphoma
Study Number(s)
S0213

Numbers of lymphoma associated macrophages (LAMS) and regulatory T-cells (Tregs) in follicular lymphoma (FL) patients (pts) treated with and without monoclonal antibody (MoAb)-containing therapy do not correlate with overall survival (OS): a study from the Southwest Oncology Group (SWOG)

Authors
JW Sweetenham;E Hsi;B Goldman;M LeBlanc;RR Tubbs;JR Cook;OW Press;RI Fisher;LM Rimsza
Journal / Conference
Blood 110(11):#2602
Year
2007
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8809, S9911

Expression of the microtubule-associated protein, tau, predicts improved survival, but not response, to a combination of docetaxel and vinorelbine in HER-2 negative metastatic breast cancer

Authors
JR Gralow;WE Barlow;AM Gown;LC Goldstein;PL Porter;IT Yeah;RB Livingston;RB Livingston;DF Hayes
Journal / Conference
San Antonio Breast Cancer Symposium #2015
Year
2007
Research Committee(s)
Breast
Study Number(s)
S0102

Vorinostat (suberoylanilide hydroxamic acid) in relapsed or refractory Hodgkin lymphoma: SWOG 0517

Authors
MH Kirschbaum;BH Goldman;JM Zain;JR Cook;LM Rimsza;SJ Forman;RI Fisher
Journal / Conference
Blood 110(11):#2574
Year
2007
Research Committee(s)
Lymphoma
Study Number(s)
S0517

Phase II studies of different schedules and doses of the farnesyl transferase inhibitor tipifarnib (R115777, Zarnestra, NSC-702818) for patients of age 70 or older with previously untreated acute myeloid leukemia (AML): A North American Intergroup study (S0432)

Authors
HP Erba;KJ Kopecky;MH Kirschbaum;MS Tallman;RA Larson;CL Willman;ML Slovak;HM Gundacker;FR Appelbaum
Journal / Conference
Blood 110(11):#440
Year
2007
Research Committee(s)
Leukemia
Study Number(s)
S0432

Superiority of lenalidomide (Len) plus high-dose dexamethasone (HD) compared to HD alone as treatment of newly-diagnosed multiple myeloma (NDMM): results of the randomized, double-blinded, placebo-controlled SWOG trial S0232

Authors
JA Zonder;J Crowley;MA Hussein;V Bolejack;DF Moore Sr;BP Whittenberger;MH Abidi;BGM Durie;B Barlogie
Journal / Conference
Blood 110(11):#77
Year
2007
Research Committee(s)
Myeloma
Study Number(s)
S0232

Central nervous system (CNS) relapse in agressive non-Hodgkin's lymphoma; does CNS prophylaxis work?

Authors
SH Bernstein;J Unger;M LeBlanc;RI Fisher
Journal / Conference
Blood 110(11):#520
Year
2007
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8516 (INT-0067)